Tag

Clients Archives - JAG Shaw Baker

NewsStartups
April 10, 2018

Client News: MediaGamma Closes £2 M Round

Rael Cline, Co-founder and CEO, MediaGamma Congrats to our client MediaGamma who closed a £2m round from the UCL Technology Fund in partnership with ParkWalk Advisors and the London Co-Investment…
Read More
InvestorsNews
March 6, 2018

This Week In Investor News

In investor news, our client ETF Partners recently led a £70 million deal for E-Leather, a UK environmentally friendly materials technology company using traditional leather fibres and high-powered water to…
Read More
Life SciencesNews
January 19, 2018

Life Sciences Round Up

We've seen several months of milestones from our Life Sciences clients - from funding rounds to industry recognition. Here's short round-up of their successes. INVESTMENT Our client Julz, a healthcare…
Read More
InvestorsNews
October 6, 2017

In Client News: Crane Venture Partners Leads $30 M Series C For AI Startup

Congratulations to our client, Crane Venture Partners on leading the Series C $30 Million funding round for London-based Onfido. Onfido uses artificial intelligence algorithms to help websites verify people’s identities by merely…
Read More
NewsStartups
September 13, 2017

Bossa Raises $10 Million Series A For Its Simulation Game

Worlds Adrift (Image credit: Ofrat/Bossa) Summer turns to fall, and our clients continue to show no signs of stopping. In gaming news, we advised London-based Bossa Studios on its $10…
Read More
NewsStartups
September 7, 2017

Habito Raises £18.5 Million In A Series B Round Led By Atomico

JAG Shaw Baker is proud to have advised our client Habito, on their £18.5 Million Series B round led by Atomico. The raise supports Habito, one of the standout ‘PropTech’ companies…
Read More
InvestorsNews
July 27, 2017

Atomico Leads $30 M Investment Round in AI Chip Company Graphcore

Artificial intelligence (AI) takes another step forward. Graphcore, a UK chip designer that designs chips specifically for AI, recently closed a $30 M round to support their continued expansion. The round was led by our client, Atomico and included…
Read More
Life SciencesNews
May 19, 2017

Elasmogen Inks Research Agreement To Develop New Class Of Therapeutics

Congratulations to our client Elasmogen! Elasmogen, a spin-out from Aberdeen University, alongside Canada based Feldan Therapeutics, have announced a research agreement with Amgen to develop and deliver novel intracellular biologics.…
Read More
NewsStartups
April 7, 2017

MyBuilder Acquired by HomeAdivsor

We ended March on a high note with some great M&A news for our client MyBuilder. The UK company was recently acquired by HomeAdvisor, an IAC company (NASDAQ: IAC) considered one of the largest home…
Read More
Life SciencesNews
April 4, 2017

Parkinson’s UK Partners With Sheffield University To Create New Spin Out

The promise of discovery. Our client, Parkinson's UK, has just inked a deal with Sheffield University to create a new £1million virtual biotech company, Keapstone Therapeutics. Even though charities and academia have entered into research partnerships…
Read More

A cookie is a small file of letters and numbers that we store on your browser or computer, phone or tablet hard drive if you agree. more information

INFORMATION ABOUT OUR USE OF COOKIES Our website uses cookies to distinguish you from other users of our website. This helps us to provide you with a good experience and also allows us to improve our website. By continuing to browse the website, you are agreeing to our use of cookies. A cookie is a small file of letters and numbers that we store on your browser or computer, phone or tablet hard drive if you agree. We use the following cookies: • Strictly necessary cookies. These are cookies that are required for the operation of our website. They include, for example, cookies that enable you to return to a previous page. • Analytical/performance cookies. They allow us to recognise and count the number of visitors and to see how visitors move around our website when they are using it. This helps us to improve the way our website works, for example, by ensuring that users are finding what they are looking for easily. The analytical/performance cookies are provided on our behalf by Google Inc. to aid with reporting of user behaviour, market research and improving website functionality. This user behaviour is analysed in order to improve this website. To see how this applies to Google Analytics, visit http://www.google.co.uk/intl/en/analytics/privacyoverview.html. You can stop tracking by Google Analytics by visiting https://tools.google.com/dlpage/gaoptout?hl=en-GB. COOKIE DURATION The strictly necessary session cookies are a temporary cookie which remains in the cookie file of your browser until you close the browser. The other cookies will remain in the cookie file of your browser after the closing of the browser, and will become active again when you reopen this website. The different cookies have different expiration dates. Following expiry of a cookie, a new version of that cookie will be downloaded when you next visit this website, unless you have withdrawn your consent in the meantime. You can block cookies by activating the setting on your browser that allows you to refuse the setting of all or some cookies. However, if you use your browser settings to block all cookies (including essential cookies) you may not be able to access all or parts of our website. Contact If you have any queries regarding this cookie policy please contact us at info@jagshawbaker.com.

Close